No Detail Found!

Post-Universal HBV Vaccination and Breakthrough Infections in Saudi Arabia: Three Decades of Evidence

Author(s)
Shuaibu Abdullahi Hudu Center for Health Research, Northern Border University, Arar 91431, Kingdom of Saudi Arabia; Department of Microbiology, Faculty of Medicine, Northern Border University, Arar 91431, Kingdom of Saudi Arabia
Abdulgafar Olayiwola Jimoh Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, 840232 Sokoto State, Nigeria
Abstract
In Saudi Arabia, universal hepatitis B virus (HBV) vaccination was introduced in 1989, resulting in large declines in HBV endemicity over the last three decades. This structured narrative review evaluates the published evidence (1989-2025) on long-term vaccination outcomes, breakthrough infections, occult hepatitis B infection (OBI), and future elimination challenges in Saudi Arabia. Relevant studies were identified from PubMed, Scopus, Embase, Web of Science, and regional grey literature sources and narratively synthesized. Available evidence shows a decline in HBsAg prevalence from about 8% pre-universal vaccination to <1% in vaccine-era populations, confirming the significant public health impact of the national immunization program. However, HBV DNA positivity and occult infections are still being reported, particularly in blood donors, hemodialysis patients, healthcare workers, and other high-risk groups. Suggested contributors include waning of antiHBs immunity, host immunogenetics, the predominance of genotype D, and vaccine-escape mutations. Current evidence also highlights important gaps in national molecular surveillance and sequencing data. While mass vaccination continues to be a very effective strategy for preventing chronic HBV infection, sustainable control will depend on improved molecular surveillance, targeted surveillance of high-risk groups, and evidence-based booster strategies. This review discusses the success of HBV vaccination in Saudi Arabia and the emerging post-immunization challenges pertinent to the goal of HBV elimination.
Publication Details
Page(s) 167-177
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 5, Year: 2026

Request the full text from PASTIC

Keywords
Saudi Arabia, Occult HBV, Hepatitis B, Infections, Vaccine Effectiveness
References
Hiebert-Suwondo L. . ."A 2024 global report on national policy, programs, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles.". The Lancet Gastroenterology & Hepatology, 10(2025) : 671-684.
Health Organization. "Hepatitis World,B: key facts. World .2025 .. , : .
Madihi S. . ."Advancing hepatitis B elimination: a systematic review of global immunization progress and future directions." Diagnostic Microbiology and Infectious Disease. , 111(2025) : 116666.
Lindstrand A. .2021 ."The world of immunization: achievements, challenges, and strategic vision for the next decade.". The Journal of Infectious Diseases, 224(Suppl 2) : S452-S467.
Delghandi S. .2024 ."An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination.". Heliyon, 10(17) : e37097.
Hudu S.A. .2013 ."Occult hepatitis B infection among vaccinated cohort. " Journal of Viral Hepatitis, 20(Suppl 1) : 30.
Awaidy Al,S. Al . ."Elimination of mother-to-child transmission of hepatitis B virus in Gulf Cooperation Council countries: current status and future prospects.". The American Journal of Tropical Medicine and Hygiene, 110(2024) : 32-35.
AlAteeq M. . ."Long-term immunity against hepatitis B virus after routine immunization among adults visiting primary care centers in Riyadh. Saudi Arabia." Cureus, 14(2022) : e21266.
Al-Faleh F.Z. . ."Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination program. " Journal of Infection, 38(1999) : 167-170.
Al-Faleh F.Z. . ."Integration of hepatitis B vaccine into the expanded program on immunization: the Saudi Arabian experience. " Annals of Saudi Medicine, 13(1993) : 231-236.
Alfaleh F. . ."Long-term protection of hepatitis B vaccine 18 years after vaccination. " Journal of Infection, 57(2008) : 404-409.
Hudu S.A. . ."Antibody and immune memory persistence post infant hepatitis B vaccination." Patient Preference and Adherence. , 7(2013) : 981-986.
Yang Y.T. . ."The prevalence of hepatitis B core antibody in vaccinated Chinese children: a hospital-based study. " Vaccine, 37(2019) : 458-463.
Al-Ajlan A. .2011 ."Prevalence of hepatitis B and C among students of health colleges in Saudi Arabia." Eastern Mediterranean Health Journal. , 17(10) : 759-762.
Lingawi H.S.,Afifi I.K. . ."Seroprotection of hepatitis B vaccine in dental students two decades after infant immunization and the possible need for revaccination.". European Journal of Dentistry, 17(2023) : 143-149.
Mahallawi W. . ."Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.". Annals of Saudi Medicine, 38(2018) : 413-419.
Aljumah A.A. . ."Hepatitis B care pathway in Saudi Arabia: current situation, gaps and actions.". Saudi Journal of Gastroenterology, 25(2019) : 73-80.
Alghamdi I.G. .2023 .". Hepatic Medicine: Evidence and Research, 15 : 233-247.
Madani T.A. . ."Trend in hepatitis B virus incidence during a decade of universal childhood vaccination in Saudi Arabia.". Transactions of the Royal Society of Tropical Medicine and Hygiene, 101(2007) : 278-283.
.2020 .Prevention of Mother-to-Child Transmission of Hepatitis B Virus (HBV): Guidelines on Antiviral Prophylaxis in Pregnancy. , : .
Chang M.H. .1997 ."Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children.". The New England Journal of Medicine, 336(26) : 1855-1859.
Chiang C.J. . ."Association of nationwide hepatitis B vaccination and antiviral therapy programs with end-stage liver disease burden in Taiwan." JAMA Network Open. , 5(2022) : e2222367.
Brierley R. . ."Elimination of viral hepatitis by 2030: ambitious, but achievable.". The Lancet Gastroenterology & Hepatology, 4(2019) : 88-89.
Akbar S.M.F. . ."Elimination of hepatitis by 2030: present realities and future projections." Infectious Diseases and Immunity. , 2(2022) : 3-8.
Abaalkhail F.A. . ."SASLT practice guidelines for the management of hepatitis B.". Saudi Journal of Gastroenterology, 27(2021) : 261-292.
.2020 ."Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years. , : .
Van Damme,P. Damme . ."Long-term protection after hepatitis B vaccine.". The Journal of Infectious Diseases, 214(2016) : 1-3.
Kuhns M.C. . ."Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.". Virology Journal, 16(2019) : 43.
Blanco S. . ."Breakthrough infection by hepatitis B virus in a vaccinated blood donor: an emerging threat for transfusion safety in low-endemic countries?". Journal of Medical Virology, 96(2024) : e29463.
Leong J. . ."Hepatitis B surface antigen escape mutations: indications for initiation of antiviral therapy revisited.". World Journal of Clinical Cases, 4(2016) : 71-75.
Kuijper L. .2024 ."Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection." Frontiers in Immunology. , 15 : 1505719.
Hsu H.Y. . ."Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study. " Hepatology, 61(2015) : 1183-1191.
Hennig B.J. . ."Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. " PLoS One, 3(2008) : e1898.
Bello N. . ."Overview of hepatitis B vaccine nonresponse and associated B cell amnesia: a scoping review. " Pathogens, 13(2024) : 554.
Li Z.K. .2013 ."The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis. " Vaccine, 31(40) : 4355-4361.
Macedo L.C. . ."Association of cytokine genetic polymorphisms with the humoral immune response to recombinant vaccine against HBV in infants. " Journal of Medical Virology, 82(2010) : 929-933.
Crooke S.N. .2019 ."Immunosenescence and human vaccine immune responses.". Immunity & Ageing, 16 : 25.
Alexander M. .2024 ."Pathology of diabetes-induced immune dysfunction.". International Journal of Molecular Sciences, 25(13) : 7105.
Hudu S.A. . ."An overview of hepatitis B virus surface antigen mutant in the Asia Pacific." Current Issues in Molecular Biology. , 16(2014) : 69-77.
Bugya Z. . ."Multiple levels of immunological memory and their association with vaccination. " Vaccines, 9(2021) : 174.
Al-Qahtani A.A. .2020 ."Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in Saudi Arabia: predominance of genotype D1." Infection, Genetics and Evolution. , 77 : 104051.
Araujo N. .2020 ."Comprehensive analysis of clinically significant hepatitis B virus mutations in relation to genotype, subgenotype and geographic region." Frontiers in Microbiology. , 11 : 616023.
Al-Qudari A.Y. . ."Surface gene variants of hepatitis B virus in Saudi patients.". Saudi Journal of Gastroenterology, 22(2016) : 133-138.
Piermatteo L. . ."Unexpected rise in the circulation of complex HBV variants enriched with HBsAg vaccine-escape mutations in HBV genotype D: potential impact on HBsAg detection/quantification and vaccination strategies. " Emerging Microbes & Infections, 12(2023) : 2219347.
Takuissu G.R. . ."Global epidemiology of occult hepatitis B virus infections in blood donors: a systematic review and metaanalysis. " PLoS One, 17(2022) : e0272920.
Lello Di,F. Di .2022 ."Insights into induction of the immune response by the hepatitis B vaccine.". World Journal of Gastroenterology, 28(31) : 4249-4262.
Saitta C. . ."Occult hepatitis B virus infection: an update. " Viruses, 14(2022) : 1504.
Liu H. . ."Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients.". Virology Journal, 21(2024) : 92.
Liu X. .2023 ."Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients". , 1211980 : .
Saran Al,K. Al . ."Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi hemodialysis center". Saudi Journal of Kidney Diseases and Transplantation, 25(2014) : 185-191.
Ali M.J. . ."Immune-escape mutations are prevalent among patients with a coexistence of HBsAg and anti-HBs in a tertiary liver center in the United States". Viruses, 16(2024) : 713.
Konopleva M.V. . ."Recombinant HBsAg of the wildtype and the G145R escape mutant included in the new multivalent vaccine against hepatitis B virus dramatically differ in their effects on leukocytes from healthy donors in vitro". Vaccines, 10(2022) : 235.
Das ,M.K ,Tropical Diseases . ."Temperature integrity and exposure of vaccines to suboptimal temperatures in cold chain devices at different levels in three states in India". Travel Medicine and Vaccines, 6(2020) : 8.
Washizaki A. . ."Neutralization of hepatitis B virus with vaccine-escape mutations by the hepatitis B vaccine with large-HBs antigen". Nature Communications, 13(2022) : 5207.
Alshayea A. .2016 ."Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia". Saudi Medical Journal, 37(10) : 1114-1119.
Im Y.R. .2022 ."Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis". Lancet Gastroenterology & Hepatology, 7(10) : 932-942.
Kwak M.,Kim Y. .2014 ."Occult hepatitis B virus infection". World Journal of Hepatology, 6(12) : 860-869.
Alqahtani J.M. .2014 ."Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: the need for national guidelines for health students". BMC Public Health, 14 : 577.
0

Citations

0

Downloads

14

Views